A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease
Clinical trial NCT00838110 · COMPLETED
Trial details
- NCT number
- NCT00838110
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-01-01
- Enrollment
- 742
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.